Nawwar M A, Hashem A N, Hussein S A, Swilam N F, Becker A, Haertel B, Lindequist U, El-Khatib A, Linscheid M W
Pharmazie. 2016 Mar;71(3):162-8.
Phenolic metabolite profiling and identification using high performance liquid chromatography (HPLC) coupled to high resolution accurate mass spectrometry (HR-ESI-MS) with detection of negative ions was used for assaying the complex mixture of phenolics of an aqueous ethanol leaf extract of Eugeniajambos L. (Myrtaceae). Eight known polyphenolics were tentatively identified, and, in addition, three hitherto unknown flavonol-O-glycosides were detected in the extract. These unknowns were taken as the targets and isolated by means of consecutive polyamide S6, MCI gel and repeated Sephadex LH-20 column fractionation. The isolation and purification were monitored by HPLC/ESI-MS. The isolates were subsequently identified as quercetin 3-O-xylosyl-(1"' --> 2")-O-xyloside, myricetin 7-methylether 3-O-xylosyl-(1"' --> 2")-rhamnoside and myricetin 3',5'-dimethyl ether 3-O-xylosyl-(1"'-->* 2")-O-rhamnoside. All known metabolites were also separated by applying the same chromatographic techniques. ESI-MS, ¹H and ¹³C NMR spectra were then recorded, completely interpreted and confirmed by HR-ESI-MS and 2D NMR spectroscopy. In order to get information about biological activities of E. jambos the extract was tested for radical scavenging activity by DPPH and ORAC assay. In addition, its cytotoxicity was assessed by the neutral red assay against non-tumorigenic HaCaT keratinocytes and the human bladder carcinoma cell line 5637.
采用高效液相色谱(HPLC)与高分辨率精确质谱(HR-ESI-MS)联用负离子检测法对蒲桃(桃金娘科)乙醇水叶提取物中的酚类化合物复杂混合物进行分析。初步鉴定出8种已知的多酚类化合物,此外,还在提取物中检测到3种迄今未知的黄酮醇-O-糖苷。将这些未知化合物作为目标物,通过连续的聚酰胺S6、MCI凝胶和重复的葡聚糖LH-20柱层析进行分离。分离和纯化过程通过HPLC/ESI-MS进行监测。随后将分离物鉴定为槲皮素3-O-木糖基-(1"'→2")-O-木糖苷、杨梅素7-甲醚3-O-木糖基-(1"'→2")-鼠李糖苷和杨梅素3',5'-二甲醚3-O-木糖基-(1"'→* 2")-O-鼠李糖苷。所有已知代谢物也采用相同的色谱技术进行分离。然后记录ESI-MS、¹H和¹³C NMR光谱,通过HR-ESI-MS和二维NMR光谱进行全面解释和确认。为了获取蒲桃生物活性的信息,通过DPPH和ORAC试验对提取物的自由基清除活性进行了测试。此外,通过中性红试验评估了其对非致瘤性HaCaT角质形成细胞和人膀胱癌细胞系5637的细胞毒性。
Nat Prod Commun. 2011-7
Front Pharmacol. 2022-1-24